Angela Walsh
2020
In 2020, Angela Walsh earned a total compensation of $480.7K as Vice President of Finance at Virios Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $58,500 |
|---|---|
| Option Awards | $275,918 |
| Salary | $146,250 |
| Total | $480,668 |
Walsh received $275.9K in option awards, accounting for 57% of the total pay in 2020.
Walsh also received $58.5K in non-equity incentive plan and $146.3K in salary.
Rankings
In 2020, Angela Walsh's compensation ranked 11,133rd out of 13,090 executives tracked by ExecPay. In other words, Walsh earned more than 15.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,133 out of 13,090 | 15th |
Division Manufacturing | 4,762 out of 5,618 | 15th |
Major group Chemicals And Allied Products | 1,976 out of 2,251 | 12th |
Industry group Drugs | 1,728 out of 1,951 | 11th |
Industry Pharmaceutical Preparations | 1,276 out of 1,456 | 12th |
Source: SEC filing on April 28, 2021.
Walsh's colleagues
We found five more compensation records of executives who worked with Angela Walsh at Virios Therapeutics in 2020.
2020
Greg Duncan
Virios Therapeutics
Chief Executive Officer
2020
Richard Burch
Virios Therapeutics
President
2020
William Pridgen
Virios Therapeutics
Chief Executive Officer
2020
Ralph Grosswald
Virios Therapeutics
Vice President of Operations
2020
R Gendreau
Virios Therapeutics
Chief Medical Officer
News
Virios Therapeutics CEO Greg Duncan's 2023 pay falls 39% to $567K
April 25, 2024
Virios Therapeutics CEO Greg Duncan's 2022 pay slips 15% to $937K
April 27, 2023
Virios Therapeutics CEO Greg Duncan's 2021 pay falls 69% to $1.1M
April 26, 2022
Virios Therapeutics CEO Greg Duncan receives $3.5M in 2020
April 28, 2021